The trans-omics landscape of COVID-19 - Wu, Peng; Chen, Dongsheng; Ding, Wencheng; Wu, Ping; Hou, Hongyan; Bai, Yong; Zhou, Yuwen; Li, Kezhen; Xiang, Shunian; Liu, Panhong; Ju, Jia; Guo, Ensong; et al. (Nature communications, 2021)
Keywords: 38/23; 38/43; 38/91; 631/250/2499; 631/250/2502; 631/250/255/2514; 631/553/1833; Asymptomatic; Blood; Cell activation; Coronaviruses; COVID-19; COVID-19 - genetics; COVID-19 - metabolism; Critical Illness; Depletion; Genomic analysis; Genomics - methods; Global health; Health risks; Heterogeneity; Humanities and Social Sciences; Humans; Leukocytes (neutrophilic); Lipidomics - methods; Lymphocytes; Lymphocytes T; Metabolites; Metabolomics; Metabolomics - methods; multidisciplinary; Neutrophils; Neutrophils - metabolism; Pathophysiology; Peripheral blood; Proteomics; Public health; Science; Science (multidisciplinary); Signs and symptoms; Transcriptome - genetics; Tryptophan; Viral diseases